• Overview
• Scope and Methodology
• Contraception Management
  • Contraceptive Use Worldwide
  • Contraceptive Use in the U.S.
  • Types of Contraception
  • New Contraceptive Products
  • Hormonal Contraception Products Market and Forecast
  
  
• Infertility Management
  • Treating Infertility
  • Cost of Treating Infertility
  • Infertility Pharmaceutical Market
  • ART Cycles of Treatment Performed in the United States
  • U.S. ART Market Forecast

Chapter Two: Introduction to Contraception and Fertility Management

• Overview
• Contraception Management
  • Contraceptive Use Worldwide
  • Oral Contraceptive Use Worldwide
  
  
• Types of Contraception
  • Sterilization
  • Oral Contraceptives
  • Transdermal Patch
  • Condoms
  • Injectable Contraceptives
  • Diaphragm
  • Implant
  • Spermicides
  • Intrauterine Devices
  • Sponge
  • Cervical Cap
  • Withdrawal
  • Periodic Abstinence
  • Emergency Contraception
  
  
• Infertility Management
• Infertility Evaluation
  • Female Examination
  • Male Examination
  
  
• Fertility Diagnostics
• Fertility Treatments
  • Pharmaceutical Therapy
  • Surgical Procedures
  • Artificial Insemination
  • Assisted Reproductive Technologies

Chapter Three: Contraception

• A Brief History of Contraception
• Worldwide Contraception Use
• Contraceptive Use in the United States
• Types of Contraception - Overview
• Surgical Sterilization
  • Female Sterilization
  • Male Sterilization
  
  
• Hormonal Contraceptives
  • Oral Contraceptives
  • Types of Oral Contraceptives
  • Contraceptive Implants
  • Injected Contraceptives
  • Intrauterine Hormone-Releasing Devices
  • Transdermal Contraceptive
  • Vaginal Ring
  • Emergency Contraceptives
  
  
• Prescription Contraceptive Devices
  • Cervical Devices
  • Intrauterine Devices
  
  
• Contraceptive Research and Development
  • NICHD Program: Reproductive Health in the 21st Century
  • Contraceptive Clinical Trials Network (CCTN)
  
  
• Contraceptives in R&D
  • Chemical Barriers
  • Mechanical Barrier Methods
  • Biodegradable Implants
  • Male Contraceptives
  
  
• Hormonal Contraception Product Market
  • New Contraceptive Products
  • Cost to User of Various Contraceptive Products/Procedures
  • Hormonal Contraception Products Market and Forecast
  • Hormonal Contraception Market Share
  
  
• Market Analysis
  • Oral and Injected Contraceptives
  • Contraceptive Patch Quickly Gaining Market Share
  • Hormonal Contraceptive Devices
  • Contraceptive Implants

Chapter Four: Infertility Management

• A Brief History of Infertility Management
• Overview of Infertility Management
  • SART/ASRM Clinical Guidelines
  
  
• Infertility Prevalence in U.S.
• Female Reproductive System
• Male Reproductive System
• Infertility Evaluation
  • Female Endocrine System Examination
  • Pelvic Factor Investigation
  • Male Factor Infertility
  
  
• Treating Infertility
  • Pharmaceutical Treatments
  • Surgical Procedures
  • Artificial Insemination
  • Assisted Reproductive Techniques (ART)
  
  
• Infertility Pharmaceutical Treatments In R&D
  • New Research May Lead to an Oral FSH Option
  • Affect of Oral Contraceptives on IVF Treatment
  • Current R&D Programs
  • Reproductive Science in the 21st Century
  
  
• Cost of Treating Infertility
• The Infertility Pharmaceutical Market
  • World Infertility Pharmaceutical Market Forcast
  • Leading Products and Manufacturers
  • Market Analysis
  
  
• U.S. ART Treatment Market
  • ART Cycles of Treatment Performed in the United States
  • U.S. ART Market Forecast
  • IVF—Leading ART Procedure

Chapter Five: Issues and Trends in Reproductive
Medicine

• Contraception
  • Overview of Major Issues and Trends
  • Insurance Coverage for Contraceptives
  • OTC Emergency Contraception
  
  
• Infertility Management
  • Overview of Major Issues and Trends
  • Prenatal Diagnostic Techniques
  • Growing Trend of Multiple Births
  • Insurance Coverage for the Evaluation and Treatment Infertility

Chapter Six: Company Profiles

• Barr Laboratories
  • History and Lines of Business
  • Business Strategy
  • Contraception Products
  • Financial Information
  
  
• Berlex, Inc.
  • History and Lines of Business
  • Contraceptive Products
  • Financial Information
  
  
• Conceptus, Inc.
  • History and Lines of Business
  • Business Strategy
  • Contraceptive Device
  • Financial Information
  
  
• Ferring Pharmaceuticals AS
  • History and Lines of Business
  • Business Strategy
  • Fertility Products
  • Financial Information
  
  
• Organon International
  • History and Lines of Business
  • Strategic Alliance
  • Contraception Products
  • Fertility Products
  • Financial Information
  
  
• Ortho-McNeil Pharmaceutical, Inc.
  • History and Lines of Business
  • Contraception Products
  • Financial Information
  
  
• Serono, Inc.
  • History and Lines of Business
  • Strategic Research Partnerships
  • Infertility Products
  • Financial Information
  
  
• Watson Pharmaceuticals, Inc.
  • History and Lines of Business
  • Contraception Products
  • Finanacial Information
  
  
• Wyeth
  • History and Lines of Business
  • Contraception Products
  • Financial Information

Appendix A: Company Directory
Appendix B: Hormonal Contraceptives Available in the United States, 2005
Appendix C: Selected Reproductive Clinics in the United States, by State
Appendix D: Institutes, Professional Organizations and Societies in Reproductive Medicine

List of Exhibits

Chapter One: Executive Summary

• Table 1-1: Selected New Hormonal Contraceptive Products Introduced to the U.S. Market 2000-2004
• Table 1-2: User Cost of Selected Contraceptive Products and Procedure in the United States, 2004
• Table 1-3: The World Market for Hormonal Contraception Products 2000-2005
• Figure 1-1: Hormonal Contraception Products World Market Share by Type 2004
• Table 1-4: Selected Infertility Pharmaceutical Treatments Currently Available in the United States
• Table 1-5: Infertility Diagnostic and Treatment Costs in the United States by Procedure Type
• Table 1-6: World Infertility Pharmaceutical Market, 2000-2005
• Table 1-7: Number of ART Cycles of Treatment Performed in the United States 2000-2008
• Table 1-8: United States Market for ART (in Millions of U.S. Dollars) 2000-2005

Chapter Two: Introduction to Contraception and Fertility Management

• Table 2-1: Estimates of Contraceptive Use Among Married Women Ages 15-49 Worldwide, by Type and Region, 2000
• Table 2-2: Estimated Ever-Use of Oral Contraceptives and Any Contraceptive Among Married and Among Sexually Active Unmarried Women Ages 15-49 by Region, 2000

Chapter Three: Contraception

• Table 3-1: Timeline of the Development of Modern Contraceptives
• Figure 3-1: Contraceptive Use Among Couples Worldwide Percentage by Type, 2000
• Figure 3-2: Contraceptive Use in Developing Countries by Percentage Increase, 1960-2000
• Table 3-2: Percentage of Contraceptive Use Among Women of Child-Bearing Age, by Method of Contraception and Age Group in the United States
• Table 3-3: Selected Monophasic Contraceptives Currently Available in the United States
• Table 3-4: Selected Biphasic Contraceptives Available in the United States
• Table 3-5: Selected Triphasic Contraceptives Available in the United States
• Table 3-6: Selected Progesterone-only Contraceptives Available in the United States
• Table 3-7: Dedicated Emergency Contraceptices and Oral Contraceptives
• Used for Emergency Contraceptives
• Table 3-8: Selected Prescription Contraceptive Devices
• Figure 3-3: Number of New Molecular Entities Approved, 1998-2003
• Figure 3-4: Cummulative Number of Patients by Disease/Treatment 1976 to 2004
• Table 3-9: Contraceptives in Research and Development Innovator, Product, Description, and Research Status
• Table 3-10: Selected New Hormonal Contraceptive Products Introduced to the U.S. Market, 2000-2004
• Table 3-11: User Cost of Selected Contraceptive Products/Procedure in the United States 2004
• Table 3-12: The World Market for Hormonal Contraception Products 2000-2008
• Figure 3-5: Hormonal Contraception Products, World Market Share by Type, 2004
• Figure 3-6: Hormonal Contraception Products, U.S. Market Share by Type 2004
• Table 3-13: World Hormonal Contraceptive Market Share and Revenues by Competitor 2004
• Figure 3-7: World Hormonal Contraceptic Competitive Market Share 2004

Chapter Four: Infertility Management

• Figure 4-1: Phases of the Female Reproductive Cycle
• Table 4-1: Infertility Standard Screening Tests
• Table 4-2: Common Infertility Diagnostic Tests
• Table 4-3: Selected Infertility Pharmaceutical Treatments Currently
• Available in the United States
• Table 4-4: Summary of Results from the Assisted Reproductive Technology Surveillance Report in United States, 2001
• Figure 4-2: Four-Stage In Vitro Fertilization Process
• Table 4-5: Major Infertility Pharmaceutical Competitors’ Pipelines, 2005 Manufacturer, Product, Description, Development Phase
• Table 4-6: Infertility Diagnostic and Treatment Costs in the United States
• Table 4-7: World Infertility Pharmaceutical Market 2000-2008
• Table 4-8: Most Frequently Prescribed Infertility Pharmaceutical
• Brands in the United States by Category
• Table 4-9: World Fertility Pharmaceutical Market Market Share and Revenues by Competitor 2004
• Figure 4-3: Infertility Pharmaceutical Competitive Market Share 2004
• Table 4-10: Number of ART Cycles of Treatment Performed in the United States 2000-2008
• Table 4-11: Number of Live Births and Babies Delivered through Assisted Reproductive Technologies in the United States, 1997-2002
• Table 4-12: U.S. ART Market by Cycle Type (With vs Without Donor Eggs) 2000-2008
• Figure 4-4: Specific Types of ART Performed in 2002
• Figure 4-5: Live Births per Retrieval for Different Types of ART Procedures Using Fresh Nondonor Eggs or Embryos, 2002
• Figure 4-6: Expanding Use of Intracytoplasmic Sperm Injection (ICSI)
• Figure 4-7: IVF with ICSI in Comparison to IVF without ICSI, by Woman’s Age, 2002

Chapter Five: Issues and Trends in Reproductive Medicine

• Table 5-1: State Mandated Benefits: Contraceptives, 2003 Table 5-2: States that Either Mandate to Offer or Mandate to Cover Infertility Diagnosis and Treatment, 2003

Chapter Six: Company Profiles

• Table 6-1: Barr Laboratories’ Current Generic Oral Contraceptive Product Portfolio

Appendix C: Selected Reproductive Clinics in the United States, by State

• Figure C-1: Location of ART Clinics in the United States and Puerto Rico